2023
DOI: 10.1002/rmv.2464
|View full text |Cite
|
Sign up to set email alerts
|

SARS‐CoV‐2 neutralising antibody therapies: Recent advances and future challenges

Abstract: The COVID‐19 pandemic represents an unparalleled global public health crisis. Despite concerted research endeavours, the repertoire of effective treatment options remains limited. However, neutralising‐antibody‐based therapies hold promise across an array of practices, encompassing the prophylaxis and management of acute infectious diseases. Presently, numerous investigations into COVID‐19‐neutralising antibodies are underway around the world, with some studies reaching clinical application stages. The advent … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
references
References 164 publications
(276 reference statements)
0
0
0
Order By: Relevance